Optimization of Radiotherapy in Treatment of Painful Bone Metastasis

PHASE3CompletedINTERVENTIONAL
Enrollment

650

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

April 30, 2012

Study Completion Date

August 31, 2012

Conditions
PainBone Metastasis
Interventions
RADIATION

Radiotherapy

4 Gy single fraction; mandate first retreatment if moderate or severe pain persists or recurs (as measured by categorical pain scale or VAS greater than 50 mm), \>4 weeks after initial RT) retreat with 8 Gy single fraction; second retreatment is optional if moderate or severe pain recurs (as measured by categorical pain scale or VAS greater than 50 mm), retreat with 8 Gy after \> 4 weeks

RADIATION

Radiotherapy

8 Gy single fraction, mandate first retreatment if moderate or severe pain persists or recurs (as measured by categorical pain scale or VAS greater than 50 mm), \>4 weeks after initial RT) retreat with 8 Gy single fraction; second retreatment is optional if moderate or severe pain recurs (as measured by categorical pain scale or VAS greater than 50 mm), retreat with 8 Gy after \> 4 weeks

RADIATION

Radiotherapy

8 Gy in a single fraction; retreatments \> 4 weeks, using local RT fields to sites of residual or recurrent, moderate or severe pain with a single fraction of 8 Gy) ; second reirradiation with 8 Gy using local RT fields optional (at discretion of PI);

RADIATION

Radiotherapy

12 Gy in 4 fractions of 3 Gy in 2 consecutive days interfraction interval of a minimum of 6 hrs; retreatments \> 4 weeks using local RT fields to sites of residual or recurrent, moderate or severe pain with a single fraction of 8 Gy); second reirradiation with 8 Gy using local RT fields optional (at discretion of PI) ;

Trial Locations (12)

1000

Institute of Radiotherapy and Oncology, Skopje

11000

Institute of Oncology and Radiology, Belgrade

14080

Instituto Nacional de Cancerología (INCAN), Mexico City

16016

Centre Pierre et Marie Curie, Centre hospitalier universitaire Mustapha (CHU), Algiers

90020-090

Irmandade de Santa Casa de Misericordia de Porto Alegre, Porto Alegre

Unknown

Misr Oncology Center (MOC), Cairo

Maharashtra 400 012

Tata Memorial Hospital, Mumbai

08660

Institute of Oncology, University of Vilinius, Vilnius

08036

Hospital Clinic Universidad de Barcelona, Barcelona

07014

Hospital Son Dureta, Palma de Mallorca

Bab Saadoun 1006

Institut national de cancer Salah Azaiz, Tunis

HA6 2 RN

Mount Vernon Cancer Centre, Northwood

All Listed Sponsors
lead

International Atomic Energy Agency

OTHER_GOV